DNLI
Denali Therapeutics Inc. Common StockRecent alerts on DNLI
All signals →
News
Biogen, Denali to drop Parkinson’s therapy after mid-stage trial setback
11d ago
News
Biogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guidance Raised
14d ago
News
Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?
14d ago
News
Denali's (DNLI) Candidate Selected for FDA's START Pilot Program
14d ago
News
Denali Therapeutics GAAP EPS of -$0.69
25d ago
Short volume
Short volume 54% of volume (3.3σ)
26d ago
News
Privium Fund Opens $5.07 Million Denali Stake Ahead of FDA Drug Approval
27d ago
News
Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why
56d ago
SEC filing
DNLI Announces FDA Approval of AVLAYAH™ for Hunter Syndrome, 91% CSF HS Reduction, PRV Awarded
68d ago
News
Denali gains on FDA approval of lead asset
69d ago
News
Bristow Group Announces Closing of $500 Million Senior Secured Notes Offering and Extension of ABL Facility
126d ago
News
Nicox annonce sa participation à des congrès au premier semestre 2026 et la présentation prochaine de données scientifiques
133d ago
News
Denali Therapeutics Announces Board and Executive Leadership Updates
153d ago
News
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
153d ago
News
Denali Therapeutics stock holds Buy rating at Jefferies on FDA approval confidence
153d ago
News
Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
155d ago
Get push alerts for DNLI
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS